HOYA and Hitachi sign contract for endoscopic ultrasound systems

7 July 2020 (Last Updated July 7th, 2020 11:40)

Japanese companies HOYA and Hitachi have entered a long-term technical collaboration and supply agreement for endoscopic ultrasound systems (EUS).

HOYA and Hitachi sign contract for endoscopic ultrasound systems
As part of the new contract with HOYA Corporation, Hitachi will continue to supply diagnostic ultrasound systems and ultrasound sensor-related parts for endoscopic ultrasound systems. Credit: User:Kentin / Wiki Commons.

Japanese companies HOYA and Hitachi have entered a long-term technical collaboration and supply agreement for endoscopic ultrasound systems (EUS).

According to the five-year agreement, Hitachi will continue to supply diagnostic ultrasound systems and ultrasound sensor-related parts for the EUS.

EUS is used to examine and evaluate cancer staging in the liver, pancreas and bronchus.

HOYA’s Pentax Medical global president Gerald Bottero said: “We are honoured to continue our alliance with Hitachi, which began with joint research in 1983, leading to the first commercial launch of our EUS in 1990.

“The Hitachi ultrasound technology is globally recognised as an important standard in EUS with high-quality imaging, advanced software modalities and ease of use. We look forward to working with Hitachi’s world-class research teams to accelerate innovation and wide adoption in this vital space.”

PENTAX Medical is a division of HOYA Group delivering endo-imaging solutions. The company holds research and development (R&D) innovation and manufacturing centres in Japan, Europe and the US.

Commenting on the latest development, Hitachi Healthcare Business Unit chief technology officer Toshihiko Kawano said: “It is our pleasure to keep continuing the business relation of EUS with PENTAX Medical Division, HOYA Corporation.

“Hitachi and PENTAX Medical have been working together for more than 30 years and developing innovative technologies in EUS. We look forward to collaborating in the future and exploring new clinical values to provide for better diagnosis and treatment.”

Hitachi’s diagnostic imaging-related business is expected to be acquired by FUJIFILM Corporation. The company noted that the new agreement will be valid after the transfer.